drugset / Trial / NCT02005068

Ceftaroline in the Treatment of Bone and Joint Infections

NCT02005068

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a study to evaluate the efficacy of Ceftaroline in the treatment of bone and joint infections.

Timeline

Start
2013-04
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftaroline Other / unclassified 600 mg Intravenous